-Reuters
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization For Use Of Moderna’s Omicron-Targeting Bivalent Booster In The European Union
Study results show mRNA-1273.214 has demonstrated significantly higher antibody titers against Omicron BA.1 and BA.4/5 subvariants when compared with mRNA-1273
Positive recommendation follows recent amendment to
